CAS No.:339-43-5

TOXICITY DATA with REFERENCE：

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intraperitoneal	250mg/kg (250mg/kg)		National Technical Information Service. Vol. AD691-490,
mouse	LD50	intravenous	1920mg/kg (1920mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Diabetes. Vol. 6, Pg. 2, 1957.
mouse	LD50	oral	2800mg/kg (2800mg/kg)		Farmakologiya i Toksikologiya Vol. 25, Pg. 93, 1962.
mouse	LD50	subcutaneous	2640mg/kg (2640mg/kg)		Diabetes. Vol. 6, Pg. 2, 1957.
rat	LD50	intravenous	980mg/kg (980mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Diabetes. Vol. 6, Pg. 2, 1957.
rat	LD50	oral	4400mg/kg (4400mg/kg)		French Demande Patent Document. Vol. #2390165,

Consensus Reports：

Reported in EPA TSCA Inventory.

SAFETY PROFILE：

A poison by intraperitoneal route. Moderately toxic by ingestion and subcutaneous routes. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits very toxic fumes of NO_x and SO_x.

Standards and Recommendations：

 

Analytical Methods：